Literature DB >> 28041977

Induction of the MCP chemokine cluster cascade in the periphery by cancer cell-derived Ccl3.

Elena Farmaki1, Vimala Kaza1, Athanasios G Papavassiliou2, Ioulia Chatzistamou3, Hippokratis Kiaris4.   

Abstract

The induction of localized pro-inflammatory niches in the periphery is instrumental in metastasis. In order to better understand how tumors engage distal sites and activate a pro-inflammatory response we utilized syngeneic breast cancers as a model and showed that soluble factors from the neoplastic epithelium activate the expression of the monocyte chemoattractive protein (MCP) chemokines of the mouse 11C cluster that include Ccl1, Ccl2, Ccl7, Ccl8, Ccl11 and Ccl12. Tissues such as the lungs and the brain, that are more prone to colonization by breast cancer cells, were more sensitive to MCP cluster chemokine induction than others such as the liver. Subsequent analyses involving chemokine arrays in breast cancer cells and media followed by functional validation assays in in vitro and in vivo identified the cytokine Ccl3 as the principle mediator of the communication between the neoplastic epithelium and the peripheral tissues in terms of MCP cluster chemokine induction. Our results show that MCP chemokines are activated in peripheral tissues of breast cancer-bearing mice, by a mechanism that involves breast cancer cell-derived Ccl3. Interference with the expression of cancer cell-derived Ccl3 may find application in the management of breast cancer metastases.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; CCL3; Chemokine; Inflammation; Metastasis; Periphery

Mesh:

Substances:

Year:  2016        PMID: 28041977      PMCID: PMC5313349          DOI: 10.1016/j.canlet.2016.12.028

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  32 in total

1.  Sustained enhanced growth of carcinoma EO771 in C57 black mice.

Authors:  A E CASEY; W R LASTER; G L ROSS
Journal:  Proc Soc Exp Biol Med       Date:  1951-06

2.  The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.

Authors:  M D Sternlicht; A Lochter; C J Sympson; B Huey; J P Rougier; J W Gray; D Pinkel; M J Bissell; Z Werb
Journal:  Cell       Date:  1999-07-23       Impact factor: 41.582

3.  CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.

Authors:  Bin-Zhi Qian; Jiufeng Li; Hui Zhang; Takanori Kitamura; Jinghang Zhang; Liam R Campion; Elizabeth A Kaiser; Linda A Snyder; Jeffrey W Pollard
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

Review 4.  Targeting CCL11 in the treatment of ovarian cancer.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Expert Opin Ther Targets       Date:  2010-02       Impact factor: 6.902

Review 5.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 6.  The chemokine and chemokine receptor superfamilies and their molecular evolution.

Authors:  Albert Zlotnik; Osamu Yoshie; Hisayuki Nomiyama
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

7.  IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.

Authors:  Kelly Kersten; Chris W Doornebal; Seth B Coffelt; Jorieke Weiden; Kim Vrijland; Cheei-Sing Hau; Niels J M Verstegen; Metamia Ciampricotti; Lukas J A C Hawinkels; Jos Jonkers; Karin E de Visser
Journal:  Nature       Date:  2015-03-30       Impact factor: 49.962

8.  Ensembl 2014.

Authors:  Paul Flicek; M Ridwan Amode; Daniel Barrell; Kathryn Beal; Konstantinos Billis; Simon Brent; Denise Carvalho-Silva; Peter Clapham; Guy Coates; Stephen Fitzgerald; Laurent Gil; Carlos García Girón; Leo Gordon; Thibaut Hourlier; Sarah Hunt; Nathan Johnson; Thomas Juettemann; Andreas K Kähäri; Stephen Keenan; Eugene Kulesha; Fergal J Martin; Thomas Maurel; William M McLaren; Daniel N Murphy; Rishi Nag; Bert Overduin; Miguel Pignatelli; Bethan Pritchard; Emily Pritchard; Harpreet S Riat; Magali Ruffier; Daniel Sheppard; Kieron Taylor; Anja Thormann; Stephen J Trevanion; Alessandro Vullo; Steven P Wilder; Mark Wilson; Amonida Zadissa; Bronwen L Aken; Ewan Birney; Fiona Cunningham; Jennifer Harrow; Javier Herrero; Tim J P Hubbard; Rhoda Kinsella; Matthieu Muffato; Anne Parker; Giulietta Spudich; Andy Yates; Daniel R Zerbino; Stephen M J Searle
Journal:  Nucleic Acids Res       Date:  2013-12-06       Impact factor: 16.971

9.  Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways.

Authors:  Yeo Song Lee; So-Young Kim; Su Jeong Song; Hye Kyung Hong; Yura Lee; Bo Young Oh; Woo Yong Lee; Yong Beom Cho
Journal:  Oncotarget       Date:  2016-06-14

10.  PROGgene: gene expression based survival analysis web application for multiple cancers.

Authors:  Chirayu Pankaj Goswami; Harikrishna Nakshatri
Journal:  J Clin Bioinforma       Date:  2013-10-28
View more
  8 in total

1.  Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic Leukemia.

Authors:  Zhao Xu; Yifeng Sun; Zheng Wei; Jifeng Jiang; Jiadai Xu; Peng Liu
Journal:  Onco Targets Ther       Date:  2020-07-16       Impact factor: 4.147

Review 2.  Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity.

Authors:  Sugandha Saxena; Rakesh K Singh
Journal:  Cancer Metastasis Rev       Date:  2021-05-06       Impact factor: 9.264

Review 3.  CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands.

Authors:  Jan Korbecki; Szymon Grochans; Izabela Gutowska; Katarzyna Barczak; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

4.  Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer.

Authors:  Zhe Gong; Jieyun Zhang; Weijian Guo
Journal:  Cancer Med       Date:  2020-10-08       Impact factor: 4.452

5.  Reduced IQGAP2 expression promotes EMT and inhibits apoptosis by modulating the MEK-ERK and p38 signaling in breast cancer irrespective of ER status.

Authors:  Dinesh Kumar; Saket Awadesbhai Patel; Md Khurshidul Hassan; Nachiketa Mohapatra; Niharika Pattanaik; Manjusha Dixit
Journal:  Cell Death Dis       Date:  2021-04-12       Impact factor: 8.469

6.  CD200 Blockade Modulates Tumor Immune Microenvironment but Fails to Show Efficacy in Inhibiting Tumor Growth in a Murine Model of Melanoma.

Authors:  Fatemeh Talebian; Jianyu Yu; Kimberly Lynch; Jin-Qing Liu; William E Carson; Xue-Feng Bai
Journal:  Front Cell Dev Biol       Date:  2021-10-08

7.  Equal Pro-inflammatory Profiles of CCLs, CXCLs, and Matrix Metalloproteinases in the Extracellular Microenvironment In Vivo in Human Dense Breast Tissue and Breast Cancer.

Authors:  Annelie Abrahamsson; Anna Rzepecka; Charlotta Dabrosin
Journal:  Front Immunol       Date:  2018-01-16       Impact factor: 7.561

Review 8.  Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors.

Authors:  David Argyle; Takanori Kitamura
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.